Future studies would include confirming p53 interactions with the aforementioned mitochondrial proteins, along with formulating a cohesive timeline for the changing metabolic phenotypes associated with p53’s evolving role as a master metabolic regulator in normal mammary cells and breast cancer cell evolution. This evidence concerns the gene TP53 and breast cancer.